(Q40886498)

24 September 2017

Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial (English)

1 reference

24 September 2017

phase III clinical trial

0 references

preterm infant

0 references

Bifidobacterium breve

1 reference

0 references

Kate Costeloe

1

1 reference

24 September 2017

Pollyanna Hardy

2

1 reference

24 September 2017

Edmund Juszczak

3

1 reference

24 September 2017

Mark Wilks

4

1 reference

24 September 2017

Michael R Millar

5

1 reference

24 September 2017

Probiotics in Preterm Infants Study Collaborative Group

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

25 November 2015

1 reference

24 September 2017

1 reference

24 September 2017

387

1 reference

24 September 2017

649-660

1 reference

24 September 2017

10019

1 reference

Deaths in Preterm Infants: Changing Pathology Over 2 Decades

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Long-term impact of infection on the preterm neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotics for prevention of necrotizing enterocolitis in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Cross sectional stature and weight reference curves for the UK, 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Bacterial colonization, probiotics, and necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Bacterial colonization and gut development in preterm neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotic bacteria and intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

A comparison of two probiotic strains of bifidobacteria in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotics: are we ready for routine use?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Bifidobacterium longum bacteremia in preterm infants receiving probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

The yin and yang of bacterial resilience in the human gut microbiota

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901027-2

7 January 2021

10.1016/S0140-6736(15)01027-2

Identifiers

DOI

1 reference

24 September 2017

1 reference